The tools exist to radically accelerate R&D and digitise labs. In this session we’ll cover at least 4 key opportunities:

1) Towards novel biology insights (beyond modelling)

2) Fast screening, hit & lead identification -> use of generative AI (DALL-E alike tools) both for small molecules, and the broad area of biologicals, beyond antibodies

3) Preclinical research using digital twins

4) Digital & remote Lab operations